Although detrimental in the natural course of HIV infection, the tolerogenic environment in early life can be exploited in the context of early initiation of ART by maintaining very low levels of T-cell immune activation and CCR5 expression, adding another barrier to viral seeding while preserving the effector potential of these T-cells. Here, CCR5 is linked to HIV infectious disease.